A recent study suggests that individuals who come off blockbuster slimming jabs like Wegovy and Mounjaro may regain shed pounds at a significantly accelerated pace than those who end conventional diet and exercise regimens.
Published data in a leading health publication demonstrates that while overweight individuals can lose substantial amounts of their body weight while using the jabs, the mass comes back at an estimated rate of 0.8 kg per month once they quit.
"People buying these treatments need to be aware of the danger of rapid rebound weight gain when the medication is stopped," stated lead investigator Dr. Susan Jebb.
This pace of recovery implies a reversion to starting mass in about 18 months.
Weighing Approaches
The analysis, which reviewed dozens of trials involving over 9,000 of patients, compared the effects of the injectable medications with older methods.
Scientists emphasize that people who shed pounds through diet and exercise usually see a more gradual weight regain—perhaps 100 grams monthly—post-intervention.
Explaining the Quick Rebound
Nutrition scientists propose the mode of action of the injections accounts for the amplified rebound.
GLP-1 drugs imitate a body's own chemical called GLP-1, which helps regulate hunger.
"Artificially providing the hormone levels several times higher than the body's typical production might result in the body to generate a reduced amount of its own natural GLP-1, and could reduce sensitivity to its actions," said Dr. Adam Collins, a nutrition researcher.
"Stopping of this medication leads to hunger is no longer kept in check, making binge eating much more probable."
An Ongoing Issue?
Medical guidelines advise the jabs for individuals with weight-linked health risks, accompanied by recommended diet and exercise modifications.
A number of clinicians argue that, given the likelihood of relapse, the treatment is often life-long.
This opinion is echoed by drug manufacturers, who state that the results "highlight the chronic character of excess weight," similar to managing diseases like diabetes.
Patient Testimonies
Users who have discontinued the medication explain a sudden return of hunger.
"It felt as if something that goes on and I was suddenly starving," recalled an individual.
This difficulty is exacerbated if individuals have not developed lasting dietary or behavioural modifications during treatment.
Significant Interest
Figures indicate that millions of people in the UK have used these injections in the past year, with interest continuing to grow.
- Use is higher among women than men.
- The middle-aged age group shows the greatest level of interest.
- Many obtain the drugs through private healthcare rather than the NHS.
Finally, researchers caution that while GLP-1 drugs are potent tools for weight loss, they are not a permanent solution and long-term success hinges on combined behavioural changes.
